Pregnant Women

This video promotes the hepatitis B birth dose as a critical first step in protecting newborns from lifelong infection and liver cancer. It emphasizes that most people with hepatitis B are unknowingly infected at birth and that early vaccination is safe, effective, and the world’s first anti-cancer vaccine.

This fact sheet presents key talking points emphasizing the critical importance of administering the hepatitis B vaccine birth dose to newborns. 

This report outlines progress toward eliminating mother-to-child transmission of hepatitis B virus (HBV) in the Americas from 2012 to 2022. It highlights improvements in vaccination coverage, including birth doses, but also notes coverage declines in some countries, which could hinder elimination goals. The report emphasizes the need for maintaining high vaccination rates, expanding hepatitis B testing for pregnant women, and ensuring timely treatment for newborns.